This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Astellas Pharma Inc.Adverse Event of FG-2216 for the Treatment of Anemia. Media Release: 7 May 2007. Available from: URL: http://www.astellas.com
About this article
Cite this article
Astellas Pharma Inc has announced that, in the US phase II clinical trial of FG-2216. React. Wkly. 1151, 3 (2007). https://doi.org/10.2165/00128415-200711510-00007
- Public Health
- Clinical Trial
- Fulminant Hepatitis